RxDoctor Payments Data

Monica Norris, MD

Family Medicine · Allentown, PANPI 1730169939

Payments from drug & device makers

$1,093in general payments, 2019–2025

Across 65 payments — averaging $16.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$246
  • Pfizer$152
  • AbbVie$96
  • Astellas Pharma US Inc$85
  • Sanofi-aventis U.S. LLC$62
  • Sumitomo Pharma America, Inc.$45
  • plus $408 from 18 others

What the payments were for

  • Food & beverage$1,07999%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,093 in reported general payments places this provider in the 70th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$469,050
Medicare patients
206
Services billed
5,647

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban66$43,271
XareltoRivaroxaban33$20,594
JardianceEmpagliflozin33$18,449
JanuviaSitagliptin Phosphate26$11,772
MyrbetriqMirabegron20$10,121
FarxigaDapagliflozin Propanediol15$8,657
Memantine Hcl81$4,154
Fosfomycin Tromethamine11$3,601
Atorvastatin Calcium253$3,505
Balsalazide Disodium12$3,236
Metoprolol Succinate135$2,639
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog28$2,518
Sertraline Hcl272$2,316
Rosuvastatin Calcium101$2,265
Levothyroxine Sodium203$2,258

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$152$43,27166 claims
Johnson & JohnsonXarelto$31$20,59433 claims
Boehringer IngelheimJardiance$12$18,44933 claims
MerckJanuvia$29$11,77226 claims
Astellas Pharma US IncMyrbetriq$85$10,12120 claims
AstraZenecaFarxiga$246$8,65715 claims
AbbVieSynthroid$96$1,98134 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Allentown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →